JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Timothy J. Gardner
Y. Joseph Woo
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berry, M. F.
Right arrow Articles by Woo, Y. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berry, M. F.
Right arrow Articles by Woo, Y. J.
Related Collections
Right arrow Cardiac - physiology
Right arrow Congestive Heart Failure
Right arrow Myocardial infarction

J Thorac Cardiovasc Surg 2004;128:866-875
© 2004 The American Association for Thoracic Surgery


Cardiopulmonary Support And Physiology

Targeted overexpression of leukemia inhibitory factor to preserve myocardium in a rat model of postinfarction heart failure

Mark F. Berry, MDa, Timothy J. Pirollia, Vasant Jayasankar, MDa, Kevin J. Morinea, Mireille A. Moise, MDa, Omar Fisher, BSa, Timothy J. Gardner, MDa, Paul H. Patterson, PhDb, Y. Joseph Woo, MDa,*

a Department of Surgery, Division of Cardiothoracic Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pa, USA
b Division of Biology, California Institute of Technology, Pasadena, Calif, USA

Read at the Eighty-fourth Annual Meeting of The American Association for Thoracic Surgery, Toronto, Ontario, Canada, April 25-28, 2004.

Received for publication April 12, 2004; revisions received June 16, 2004; accepted for publication June 22, 2004.

* Address for reprints: Y. Joseph Woo, MD, Division of Cardiothoracic Surgery, University of Pennsylvania School of Medicine, 6 Silverstein Pavilion, 3400 Spruce St, Philadelphia, PA 19104 (E-mail: wooy{at}uphs.upenn.edu).

OBJECTIVE: Myocardial infarction leads to cardiomyocyte loss. The cytokine leukemia inhibitory factor regulates the differentiation and growth of embryonic and adult heart tissue. This study examined the effects of gene transfer of leukemia inhibitory factor in infarcted rat hearts.

METHODS: Lewis rats underwent ligation of the left anterior descending coronary artery and direct injection of adenovirus encoding leukemia inhibitory factor (n = 10) or null transgene as control (n = 10) into the myocardium bordering the ischemic area. A sham operation group (n = 10) underwent thoracotomy without ligation. After 6 weeks, the following parameters were evaluated: cardiac function with a pressure-volume conductance catheter, left ventricular geometry and architecture by histologic methods; myocardial fibrosis by Masson trichrome staining, apoptosis by terminal deoxynucleotidal transferase–mediated deoxyuridine triphosphate nick-end labeling assay, and cardiomyocyte size by immunofluorescence.

RESULTS: Rats with overexpression of leukemia inhibitory factor had more preserved myocardium and less fibrosis in both the infarct and its border zone. The border zone in leukemia inhibitory factor–treated animals contained fewer apoptotic nuclei (1.6% ± 0.1% vs 3.3% ± 0.2%, P < .05) than that in control animals and demonstrated cardiomyocytes with larger cross-sectional areas (910 ± 60 µm2 vs 480 ± 30 µm2, P < .05). Leukemia inhibitory factor–treated animals had increased left ventricular wall thickness (2.1 ± 0.1 mm vs 1.8 ± 0.1 mm, P < .05) and less dilation of the left ventricular cavity (237 ± 22 µL vs 301 ± 16 µL, P < .05). They also had improved cardiac function, as measured by maximum change in pressure over time (3950 ± 360 mm Hg/s vs 2750 ± 230 mm Hg/s, P < .05) and the slopes of the maximum change in pressure over time–end-diastolic volume relationship (68 ± 5 mm Hg/[s · µL] vs 46 ± 6 mm Hg/[s · µL], P < .05) and the preload recruitable stroke work relationship (89 ± 10 mm Hg vs 44 ± 4 mm Hg, P < .05).

CONCLUSIONS: Myocardial gene transfer of leukemia inhibitory factor preserved cardiac tissue, geometry, and function after myocardial infarction in rats.





This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Kurdi and G. W. Booz
JAK redux: a second look at the regulation and role of JAKs in the heart
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1545 - H1556.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.